PRODUCT DEVELOPMENT SERVICES
Clinical Pharmacodynamics
In recent years there has been increasing interest in the application of
biomarkers and surrogate endpoints in healthy volunteer studies to provide
pivotal information on efficacy, dose-response and time-effects of drugs. ICON
has worked extensively in this area, developing and validating models for
investigating a range of therapeutic targets, as part of its own research
and development efforts and in partnership with Sponsors.